No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AZTA Azenta
- 50.650
- +0.160+0.32%
Close Apr 19 16:00 ET
- 50.650
- 0.0000.00%
Post 16:06 ET
2.82BMarket Cap-144714P/E (TTM)
50.943High50.110Low436.78KVolume50.520Open50.490Pre Close22.07MTurnover0.88%Turnover RatioLossP/E (Static)55.77MShares69.16052wk High1.16P/B2.52BFloat Cap36.01052wk Low--Dividend TTM49.84MShs Float124.679Historical High--Div YieldTTM1.65%Amplitude1.980Historical Low50.522Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
What Is Azenta, Inc.'s (NASDAQ:AZTA) Share Price Doing?
While Azenta, Inc. (NASDAQ:AZTA) might not have the largest market cap around , it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasi
Azenta Is Maintained at In-Line by Evercore ISI Group
Azenta Is Maintained at In-Line by Evercore ISI Group
Express News | Evercore ISI Group Maintains In-Line on Azenta, Lowers Price Target to $60
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Comments
Insider selling at Azenta, even at a lower share price, implies they considered it reasonable. Despite some alignment with common shareholders, the lack of insider buying over the past year is discouraging.
Azenta Insiders Sold US$1.7m Of Shares Suggesting HesitancyThe elevated P/S ratio of Azenta shows the market's faith in its capacity to weather global industry headwinds. This is why Azenta's P/S ratio outpaces most other firms. Shareholder sentiment may remain steady barring any shift in these circumstances.
Azenta stock may not be an optimal investment now considering the negative growth outlook and fair valuation. Its high beta could offer future trades if market conditions change.
The large sales by insiders, even at a price below the current rate, are seen as a potentially discouraging sign. However, insiders owning a reasonable chunk of the company indicates an alignment of interests with other shareholders.
Despite Azenta's falling revenues and non-profitability, the stock has delivered respectable returns. The link between past revenue performance and share price remains murky. A recent uptick in one-year TSR Vs five-year TSR suggests potentially growing business momentum.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg